0.3857
price up icon0.11%   0.0192
after-market Handel nachbörslich: .40 0.0143 +3.71%
loading
Schlusskurs vom Vortag:
$0.4049
Offen:
$0.3806
24-Stunden-Volumen:
90,290
Relative Volume:
0.04
Marktkapitalisierung:
$9.63M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.80M
KGV:
-0.3241
EPS:
-1.19
Netto-Cashflow:
$-25.19M
1W Leistung:
+6.11%
1M Leistung:
-20.26%
6M Leistung:
-31.76%
1J Leistung:
-60.26%
1-Tages-Spanne:
Value
$0.3756
$0.4078
1-Wochen-Bereich:
Value
$0.3301
$0.4093
52-Wochen-Spanne:
Value
$0.25
$1.94

Sensei Biotherapeutics Inc Stock (SNSE) Company Profile

Name
Firmenname
Sensei Biotherapeutics Inc
Name
Telefon
(240) 243-8000
Name
Adresse
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Name
Mitarbeiter
15
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-28
Name
Neueste SEC-Einreichungen
Name
SNSE's Discussions on Twitter

Vergleichen Sie SNSE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SNSE
Sensei Biotherapeutics Inc
0.3857 9.63M 0 -29.80M -25.19M -1.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.49 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.86 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
620.97 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.85 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.46 24.70B 3.81B -644.79M -669.77M -6.24

Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-14 Eingeleitet Stephens Overweight
2021-07-01 Herabstufung Berenberg Buy → Hold
2021-06-29 Herabstufung Oppenheimer Outperform → Perform
2021-03-01 Eingeleitet Berenberg Buy
2021-03-01 Eingeleitet Citigroup Buy
2021-03-01 Eingeleitet Oppenheimer Outperform
2021-03-01 Eingeleitet Piper Sandler Overweight
Alle ansehen

Sensei Biotherapeutics Inc Aktie (SNSE) Neueste Nachrichten

pulisher
Apr 11, 2025

SEC Form DEF 14A filed by Sensei Biotherapeutics Inc. - Quantisnow

Apr 11, 2025
pulisher
Apr 03, 2025

Penny Stocks To Add to Your WatchlistMarch 30th - MarketBeat

Apr 03, 2025
pulisher
Apr 02, 2025

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Promising Penny Stocks To ResearchMarch 29th - MarketBeat

Apr 02, 2025
pulisher
Apr 02, 2025

Best Penny Stocks To Follow NowMarch 28th - MarketBeat

Apr 02, 2025
pulisher
Mar 31, 2025

Sensei Biotherapeutics stock hits 52-week low at $0.34 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Sensei Biotherapeutics stock hits 52-week low at $0.34 - Investing.com

Mar 31, 2025
pulisher
Mar 30, 2025

HC Wainwright Reiterates Buy Rating for Sensei Biotherapeutics (NASDAQ:SNSE) - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Expected to Rise, Oppenheimer Analyst Says - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Sensei Biotherapeutics (NASDAQ:SNSE) Price Target Raised to $4.00 at Oppenheimer - Armenian Reporter

Mar 30, 2025
pulisher
Mar 29, 2025

Sensei Biotherapeutics Reports Promising 2024 Results - TipRanks

Mar 29, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics (SNSE) Reports Annual Loss and Decline in Cash Reserves - GuruFocus

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei stock holds Buy rating, $4 target from H.C. Wainwright By Investing.com - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Rockets on FY ’24 Results - Baystreet.ca

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors - Benzinga

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics price target raised to $4 from $3.50 at Oppenheimer - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Oppenheimer Adjusts Price Target on Sensei Biotherapeutics to $4 From $3.50, Maintains Outperform Rating - Marketscreener.com

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics reports FY24 EPS ($1.20) vs ($1.22) last year - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei stock holds Buy rating, $4 target from H.C. Wainwright - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics Inc Cash Runway Into Q2 Of 2026 - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress - GlobeNewswire

Mar 28, 2025
pulisher
Mar 28, 2025

Breakthrough: Sensei's Cancer Drug Triples Response Rate in Hard-to-Treat Tumors - Stock Titan

Mar 28, 2025
pulisher
Mar 27, 2025

Sensei Biotherapeutics announces initial results from solnerstotug trial portion - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data For Solnerstotug In PD-(L)1 Resistant Tumors - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

Sensei Biotherapeutics : Company Presentation March 2025 - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Revolutionary Cancer Treatment Triples Response Rate in Hard-to-Treat Tumors: Clinical Trial Results Revealed - Stock Titan

Mar 27, 2025
pulisher
Mar 21, 2025

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Sees Large Drop in Short Interest - Defense World

Mar 21, 2025
pulisher
Mar 07, 2025

Sensei Biotherapeutics Stock Price, Quotes and Forecasts | NASDAQ:SNSE - Benzinga

Mar 07, 2025
pulisher
Feb 24, 2025

Sensei Biotherapeutics Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Feb 24, 2025
pulisher
Feb 19, 2025

Sensei Biotherapeutics (SNSE) to Release Quarterly Earnings on Wednesday - Defense World

Feb 19, 2025
pulisher
Feb 07, 2025

What Makes Sensei Biotherapeutics (SNSE) a New Buy Stock - MSN

Feb 07, 2025
pulisher
Feb 06, 2025

A stock that deserves closer examination: Sensei Biotherapeutics Inc (SNSE) - US Post News

Feb 06, 2025
pulisher
Feb 04, 2025

Sensei Biotherapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference - GlobeNewswire

Feb 04, 2025
pulisher
Feb 04, 2025

Sensei Biotherapeutics to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference - The Manila Times

Feb 04, 2025
pulisher
Feb 04, 2025

Biotech Spotlight: Sensei Bio Takes Center Stage at Major Healthcare Conference - StockTitan

Feb 04, 2025
pulisher
Jan 27, 2025

Sensei Biotherapeutics, Inc. Appoints Robert Pierce as Chief Scientific Officer; Opens its Boston Office - Marketscreener.com

Jan 27, 2025
pulisher
Jan 11, 2025

Sensei Biotherapeutics Inc Shares Rise 25.49% From The Lows – But Will They Continue? - Marketing Sentinel

Jan 11, 2025
pulisher
Jan 10, 2025

Biotech Advances Breakthrough Cancer Treatment Results - Streetwise Reports

Jan 10, 2025
pulisher
Jan 10, 2025

Sensei Biotherapeutics (NASDAQ:SNSE) Earns Buy Rating from HC Wainwright - Defense World

Jan 10, 2025
pulisher
Jan 08, 2025

Sensei Biotherapeutics faces Nasdaq delisting risk By Investing.com - Investing.com Australia

Jan 08, 2025
pulisher
Jan 08, 2025

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones - The Manila Times

Jan 08, 2025
pulisher
Jan 08, 2025

Sensei Bio's Cancer Drug Shows Promise in Phase 1/2 Trial, Enrolls 45 Patients for VISTA Study - StockTitan

Jan 08, 2025
pulisher
Jan 08, 2025

Sensei Biotherapeutics faces Nasdaq delisting risk - Investing.com

Jan 08, 2025
pulisher
Nov 27, 2024

Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference - GlobeNewswire

Nov 27, 2024
pulisher
Nov 18, 2024

Sensei Biotherapeutics Q3 2024 Results and Strategic Moves - TipRanks

Nov 18, 2024

Finanzdaten der Sensei Biotherapeutics Inc-Aktie (SNSE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.64
price up icon 0.12%
$69.86
price up icon 0.12%
$32.54
price up icon 1.01%
$24.11
price up icon 2.49%
$104.00
price up icon 1.93%
biotechnology ONC
$249.46
price up icon 1.94%
Kapitalisierung:     |  Volumen (24h):